To all whom these Presents shall come
or may Concern, Know That
FORTICELL BIOSCIENCE, INC.,
on behalf of itself and its
subsidiaries, as RELEASOR, in consideration of the general release
dated the date hereof and received from Paul Royalty Fund L.P. (the
"PRF Forticell Release"), receipt of which is hereby acknowledged,
except as provided in the last sentence of this paragraph releases
and forever discharges PAUL ROYALTY FUND L.P., its
affiliates and their respective partners, managers, directors,
officers and employees, and all current and former members of the
Board of Directors of RELEASOR that have been designated by Paul
Royalty Fund L.P., and each of their respective heirs, executors,
administrators, successors and assigns (each, a "RELEASEE"), from
all actions, causes of action, suits, debts, dues, sums of money,
accounts reckonings, bonds, bills, specialties, covenants,
contracts, controversies, agreements, promises, variances,
trespasses, damages, judgments, extents, executions, claims and
demands whatsoever, in law, admiralty or equity, which against such
RELEASEE, the RELEASOR and the RELEASOR'S heirs, executors,
administrators, successors and assigns ever had, now have or
hereafter can, shall or may, have for, upon, or by reason of any
matter, cause or thing whatsoever from the beginning of the world
to the day of the date of this RELEASE. This RELEASE includes but
is not limited to, all of Paul Royalty Fund L.P.'s obligations to
the RELEASOR pursuant to the Amended and Restated Exchange
Agreement between Paul Royalty Fund L.P. and the RELEASOR (then
known as Ortec International,
